- Venture Corp (SGX:V03)’s 2022 earnings of S$370m (+18% y-o-y) were slightly above our estimate. All of its seven domains recorded growth due to strong customer demand, especially for life science, healthcare and test & measurement.
- - Read this at SGinvestors.io -
- Maintain BUY and target price of S$20.20.
Venture Corp's 2022 results slightly above expectations
- Venture Corp’s 2022 earnings of S$370m (+18% y-o-y) were slightly above our estimate by 2%. 2022 revenue grew 24% y-o-y, reflecting robust customer demand in several technology domains and new product introductions.
- - Read this at SGinvestors.io -
- Net margin remained stable at 9.6%, which is an indication of Venture Corp’s core competencies and pricing power.
Outlook appears more balanced, indicating milder growth for 2023 after a strong 2022.
- Read more at SGinvestors.io.
Above is the excerpt from report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full report in PDF @ https://www.utrade.com.sg/.
John Cheong UOB Kay Hian Research | Heidi Mo UOB Kay Hian | https://research.uobkayhian.com/ 2023-02-27
Read also UOB's most recent report:
2023-08-08 Venture Corporation - 2Q23 Results Miss Expectations Due To Softening Demand From Customers.
Previous report by UOB:
2023-05-08 Venture Corporation - Expect Near-Term Weakness; Downgrade To HOLD.
Price targets by 5 other brokers at Venture Corp Target Prices.
Listing of research reports at Venture Corp Analyst Reports.
Relevant links:
Venture Corp Share Price History,
Venture Corp Announcements,
Venture Corp Dividends & Corporate Actions,
Venture Corp News Articles
